Accéder au contenu
Merck

BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity.

Cancer research (2014-09-17)
Yuan Cao, Clare Y Slaney, Bradley N Bidwell, Belinda S Parker, Cameron N Johnstone, Jai Rautela, Bedrich L Eckhardt, Robin L Anderson
RÉSUMÉ

The TGFβ growth factor family member BMP4 is a potent suppressor of breast cancer metastasis. In the mouse, the development of highly metastatic mammary tumors is associated with an accumulation of myeloid-derived suppressor cells (MDSC), the numbers of which are reduced by exogenous BMP4 expression. MDSCs are undetectable in naïve mice but can be induced by treatment with granulocyte colony-stimulating factor (G-CSF/Csf3) or by secretion of G-CSF from the tumor. Both tumor-induced and G-CSF-induced MDSCs effectively suppress T-cell activation and proliferation, leading to metastatic enhancement. BMP4 reduces the expression and secretion of G-CSF by inhibiting NF-κB (Nfkb1) activity in human and mouse tumor lines. Because MDSCs correlate with poor prognosis in patients with breast cancer, therapies based on activation of BMP4 signaling may offer a novel treatment strategy for breast cancer. Cancer Res; 74(18); 5091-102. ©2014 AACR.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-Cytokeratin, pan antibody, Mouse monoclonal, clone PCK-26, purified from hybridoma cell culture
Sigma-Aldrich
Human BMP-4 ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
Human BMP-4 ELISA Kit, for cell and tissue lysates